ESTEVE has entered into an agreement with Sanofi to acquire Caprelsa® (vandetanib) rights in more than 50 countries, a ...

A team from the Institut Curie, Inserm, and CNRS[1] has uncovered a new molecular mechanism, previously unknown, linking ...

Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to ...

Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic ...

Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...

Cure rates from differentiated thyroid cancer are high in most patients considered low-risk owing to the following characteristics: no local or distant metastases; complete macroscopic tumor ...

Discussion. Well-differentiated thyroid cancers are usually limited to the thyroid gland. The rates of distant metastasis are reported to range from 4–15%. 4 Other than the lymph nodes, the most ...

Keywords: hepatocellular carcinoma, liver cancer, thyroid metastasis, transcatheter arterial chemotherapy embolization (TACE), case report. Citation: Guan S, Ye Q, Li P and Ding L (2025) Thyroid ...

These therapeutics mobilize the body’s immune system in new ways to fight cancer. As early diagnostic techniques improve, certain kinds of cancers, such as breast cancer, melanoma, and thyroid cancer ...

1 Medical College, Shihezi University, Shihezi, China; 2 The First Affiliated Hospital of Shihezi University, Shihezi, China; 3 Department of Urology, Changzhou Cancer (Fourth People’s) Hospital, ...

It’s referred to as metastatic NSCLC when it has spread from the lungs to other parts of the body. There are several subtypes of NSCLC, depending on which type of cell the cancer originated in ...